John D Lambris Selected Research

Peptide Hydrolases (Proteases)

2/2014	Acute lung injury and fibrosis in a baboon model of Escherichia coli sepsis.
10/2013	Induction of complement C3a receptor responses by kallikrein-related peptidase 14.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John D Lambris Research Topics

Disease

68	Inflammation (Inflammations) 01/2023 - 09/2002
26	Neoplasms (Cancer) 09/2023 - 02/2005
19	Sepsis (Septicemia) 01/2022 - 07/2002
17	Periodontitis 01/2023 - 02/2010
14	Infections 01/2022 - 11/2006
11	COVID-19 08/2022 - 01/2020
10	Macular Degeneration (Age-Related Maculopathy) 12/2020 - 11/2007
8	Thromboinflammation 01/2023 - 01/2013
8	Dysbiosis 10/2022 - 11/2012
8	Thrombosis (Thrombus) 01/2019 - 12/2003
8	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2018 - 03/2014
7	Hemolysis 01/2020 - 03/2014
6	Periodontal Diseases (Periodontal Disease) 10/2021 - 11/2011
6	Bacterial Infections (Bacterial Infection) 01/2021 - 12/2008
4	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 06/2006
4	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2012
4	Disease Progression 01/2020 - 05/2010
4	Wounds and Injuries (Trauma) 01/2020 - 03/2003
4	Chronic Kidney Failure (Chronic Renal Failure) 01/2019 - 07/2010
4	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2017 - 08/2002
4	Fibrosis (Cirrhosis) 01/2017 - 10/2013
4	Respiratory Hypersensitivity 01/2013 - 03/2004
3	Hemorrhage 12/2021 - 12/2008
3	Thrombocytopenia (Thrombopenia) 11/2021 - 08/2010
3	Hemorrhagic Shock 01/2020 - 01/2019
3	Multiple Trauma (Multiple Injuries) 01/2019 - 11/2010
3	Kidney Diseases (Kidney Disease) 01/2019 - 01/2016
3	Edema (Dropsy) 01/2019 - 10/2013
3	Carcinogenesis 10/2018 - 10/2016
3	Rare Diseases (Rare Disease) 01/2016 - 09/2007
3	Smallpox (Variola) 06/2015 - 08/2003
3	Asthma (Bronchial Asthma) 01/2013 - 03/2006
3	Hereditary Complement Deficiency Diseases 11/2012 - 09/2007
2	Alveolar Bone Loss 10/2022 - 01/2011
2	Myocardial Infarction 01/2022 - 10/2018
2	Air Embolism (Gas Embolism) 01/2022 - 12/2021
2	Geographic Atrophy 01/2022 - 01/2020
2	Acute Lung Injury 01/2022 - 01/2021
2	Thrombotic Microangiopathies 11/2020 - 11/2020
2	Acute Kidney Injury (Acute Renal Failure) 01/2020 - 01/2019
2	Pneumonia (Pneumonitis) 01/2020 - 01/2013
2	Multiple Organ Failure (MODS) 01/2019 - 08/2010
2	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2019 - 09/2007
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2018 - 01/2017
2	Chronic Disease (Chronic Diseases) 10/2016 - 01/2013
2	Reperfusion Injury 04/2014 - 12/2009
2	Stroke (Strokes) 04/2014 - 01/2007
2	Atherosclerosis 03/2014 - 02/2010
2	Immune System Diseases (Immune Disorders) 01/2013 - 11/2006

Drug/Important Bio-Agent (IBA)

146	Complement System Proteins (Complement)IBA 09/2023 - 08/2002
19	Anaphylatoxin C5a ReceptorIBA 01/2018 - 07/2002
18	compstatinIBA 01/2023 - 10/2006
14	Complement C3 (C3 Complement)IBA 10/2022 - 01/2003
12	Complement Inactivating AgentsIBA 01/2023 - 10/2004
12	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2003
11	AnaphylatoxinsIBA 10/2018 - 10/2002
10	CytokinesIBA 11/2020 - 01/2003
8	Interleukin-6 (Interleukin 6)IBA 10/2022 - 01/2003
8	Peptides (Polypeptides)IBA 03/2016 - 12/2003
7	AntibodiesIBA 11/2021 - 12/2002
6	AMY-101IBA 08/2022 - 09/2017
5	Complement Receptors (Complement Receptor)IBA 01/2023 - 04/2011
5	Complement C5a (Complement 5a)IBA 01/2022 - 12/2003
5	eculizumab FDA Link 11/2020 - 09/2007
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 09/2008
4	Antigen-Antibody Complex (Immune Complex)IBA 11/2021 - 06/2006
4	Biocompatible Materials (Biomaterials)IBA 01/2013 - 01/2007
3	lepirudin (Refludan)FDA Link 01/2023 - 09/2002
3	CholesterolIBA 01/2022 - 03/2014
3	ChemokinesIBA 01/2021 - 11/2015
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2019 - 10/2014
3	Interleukin-10 (Interleukin 10)IBA 10/2013 - 05/2010
3	Messenger RNA (mRNA)IBA 08/2009 - 07/2002
3	VaccinesIBA 02/2005 - 01/2003
2	EnzymesIBA 01/2023 - 10/2018
2	Therapeutic UsesIBA 01/2023 - 12/2021
2	Interleukin-17 (Interleukin 17)IBA 10/2022 - 12/2012
2	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2022 - 01/2019
2	Complement C3-C5 Convertases (C3 Convertase)IBA 01/2022 - 05/2014
2	AntigensIBA 11/2021 - 04/2006
2	Immunoglobulin G (IgG)IBA 11/2021 - 10/2006
2	Toll-Like Receptor 4IBA 01/2021 - 01/2016
2	InterleukinsIBA 01/2021 - 04/2014
2	Thromboplastin (Tissue Factor)IBA 11/2020 - 06/2008
2	Thrombin FDA Link 11/2020 - 11/2010
2	Monoclonal AntibodiesIBA 11/2020 - 01/2014
2	Retinaldehyde (Retinal)IBA 01/2020 - 07/2015
2	Dichlorodiphenyldichloroethane (DDD)IBA 01/2019 - 09/2007
2	Complement Factor H (Factor H)IBA 01/2019 - 01/2017
2	Glycoproteins (Glycoprotein)IBA 10/2018 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 08/2010
2	Prostaglandins AIBA 01/2017 - 01/2016
2	CollagenIBA 11/2015 - 02/2014
2	Hemostatics (Antihemorrhagics)IBA 05/2014 - 08/2010
2	Peptide Hydrolases (Proteases)FDA Link 02/2014 - 10/2013

Therapy/Procedure

32	Therapeutics 01/2022 - 01/2003
5	Ligation 01/2023 - 07/2002
5	Renal Dialysis (Hemodialysis) 01/2019 - 01/2007
3	Immunotherapy 01/2019 - 01/2014
3	Transplantation 01/2016 - 01/2013